cost effectiveness
Where is Health Technology Assessment Going?
November 04 by Pharma IQChrissie Fletcher, Director and Head of International Biostatistics at Amgen, talks to Helen Winsor from Pharma IQ, about innovation in clinical design, analysis and reporting. Fletcher disc...
Health Technology Assessment Climbs Up the European Agenda due to Lack of Resources
November 03 by Andrea CharlesHealth Technology Assessment (HTA) is climbing up the agenda in many European countries due to increasing healthcare costs and budgetary pressures. Limited resource According to the European Society...